Genetic Analysis AS (XSAT:GEAN)
0.760
+0.030 (4.11%)
At close: Dec 5, 2025
Genetic Analysis AS Cash Flow Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Net Income | -9.75 | -14.77 | -23.82 | -28.27 | -29.01 | -22.14 | Upgrade
|
| Depreciation & Amortization | 1.86 | 1.69 | 2.13 | 1.38 | 1.35 | 1.54 | Upgrade
|
| Other Amortization | 3.55 | 3.55 | 3.45 | 3.45 | 3.19 | 4.66 | Upgrade
|
| Loss (Gain) on Equity Investments | 0.62 | 0.62 | 0.09 | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.34 | 0.13 | 0.44 | 0.32 | 1.22 | 2.02 | Upgrade
|
| Other Operating Activities | -0.51 | -0.06 | 0.03 | 0.01 | 0.05 | 0.08 | Upgrade
|
| Change in Accounts Receivable | 0.42 | -1.3 | 0.71 | -1.56 | -0.19 | 6.36 | Upgrade
|
| Change in Inventory | 1.08 | 0.78 | 0.22 | 0.61 | -0.48 | -1.12 | Upgrade
|
| Change in Accounts Payable | -2.02 | -0.91 | 0.97 | 2.2 | 0.68 | 0.84 | Upgrade
|
| Change in Other Net Operating Assets | 6.1 | 1.77 | -1.45 | 2.4 | -4.42 | 1.19 | Upgrade
|
| Operating Cash Flow | 1.7 | -8.5 | -17.23 | -19.46 | -27.62 | -6.56 | Upgrade
|
| Capital Expenditures | -0.81 | -0.46 | -0.14 | -0.23 | -0.08 | -0.02 | Upgrade
|
| Sale (Purchase) of Intangibles | -4.96 | -1.49 | -0.5 | - | -1.87 | -5.15 | Upgrade
|
| Investment in Securities | -0.1 | -0.1 | -0.5 | - | - | - | Upgrade
|
| Investing Cash Flow | -5.87 | -2.05 | -1.14 | -0.23 | -1.95 | -5.18 | Upgrade
|
| Long-Term Debt Issued | - | 4.4 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -1.91 | -1.89 | -1.8 | -1.06 | -1.29 | Upgrade
|
| Net Debt Issued (Repaid) | -1.88 | 2.49 | -1.89 | -1.8 | -1.06 | -1.29 | Upgrade
|
| Issuance of Common Stock | 13.82 | 5.42 | 13.62 | - | 60.33 | 34.34 | Upgrade
|
| Other Financing Activities | -1.43 | -0.29 | -2.39 | - | -7.08 | -1.14 | Upgrade
|
| Financing Cash Flow | 10.51 | 7.63 | 9.34 | -1.8 | 52.19 | 31.91 | Upgrade
|
| Net Cash Flow | 6.34 | -2.92 | -9.03 | -21.49 | 22.62 | 20.18 | Upgrade
|
| Free Cash Flow | 0.89 | -8.96 | -17.38 | -19.69 | -27.7 | -6.58 | Upgrade
|
| Free Cash Flow Margin | 4.09% | -43.29% | -75.02% | -94.88% | -207.07% | -87.30% | Upgrade
|
| Free Cash Flow Per Share | 0.01 | -0.20 | -0.66 | -0.79 | -1.11 | -0.38 | Upgrade
|
| Levered Free Cash Flow | -3.47 | -5.47 | -9.49 | -9.39 | -18.96 | -4.81 | Upgrade
|
| Unlevered Free Cash Flow | -3.42 | -5.25 | -9.33 | -9.31 | -18.88 | -4.68 | Upgrade
|
| Change in Working Capital | 5.58 | 0.34 | 0.45 | 3.65 | -4.42 | 7.28 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.